Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | SVP & CCO | August 01, 2012 | August 01, 2012 |
| EXELON CORPEXC · Entity 3050 | Director | April 28, 2026 | April 29, 2026 |
| ILLUMINA, INC.ILMN · Entity 3137 | Director | May 21, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date August 01, 2012 · Filed August 01, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,992 |
Reported balance
After 2012-08-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2012-08-01 · Exercise / conversion · Acquired 5,125 · Balance 41,992 |
| Common StockSEC Table I · non-derivative | Direct | 36,867 |
Reported balance
After 2012-08-01 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2012-08-01 · Gift · Disposed 5,125 · Balance 36,867 F1: These shares are being transferred to the reporting person's Family Trust. F2: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 20,000 RSUs which fully vest on 10/28/2013; 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015; and 3,350 RSUs which vest in three installments of 1,105, 1,106 and 1,139 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3: These shares include 1,675 shares of common stock acquired under the Company's Employee Stock Purchase Plan. F4: These shares include 17 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
| Common StockSEC Table I · non-derivative | IndirectThe Nicholas A. Moore and Anna S. Richo Family Trust | 15,381 |
Reported balance
After 2012-08-01 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2012-08-01 · Gift · Acquired 5,125 · Balance 15,381 F1: These shares are being transferred to the reporting person's Family Trust. |
| Common StockSEC Table I · non-derivative | IndirectThe Nicholas A. Moore and Anna S. Richo Family Trust | 10,256 |
Reported balance
After 2012-08-01 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2012-08-01 · Sale · Disposed 5,125 · Balance 10,256 F5: The price reported is an average price. The prices ranged from $83.04 to $83.11 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $62.63 · Expires 2015-07-31 | Direct | 0 |
Reported balance
After 2012-08-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2012-08-01 · Exercise / conversion · Disposed 5,125 · Balance 0 |
| Common StockSEC Table I · non-derivative | Indirect401(k) Plan | 2,342.0157 |
Reported balance
Holding disclosure · report date 2012-08-01 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 2,342.0157 F6: These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares are being transferred to the reporting person's Family Trust.
F2: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 20,000 RSUs which fully vest on 10/28/2013; 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015; and 3,350 RSUs which vest in three installments of 1,105, 1,106 and 1,139 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F3: These shares include 1,675 shares of common stock acquired under the Company's Employee Stock Purchase Plan.
F4: These shares include 17 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F5: The price reported is an average price. The prices ranged from $83.04 to $83.11 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
F6: These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
EXELON CORP
Report date April 28, 2026 · Filed April 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| 2026 Directors Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2027-04-28 | Direct | 3,720 |
Reported balance
After 2026-04-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-28 · Grant · Acquired 3,720 · Balance 3,720 F1: Annual restricted stock unit (RSU) award subject to the Exelon Long-term Incentive Plan (LTIP) will fully vest and be settled in shares of Exelon common stock on a 1 for 1 basis. The award will accrue additional stock units through dividend reinvestment which will vest along with the underlying award. |
| Deferred phantom share equivalentsSEC Table II · derivative / convertible security | Direct | 7,930 |
Reported balance
Holding disclosure · report date 2026-04-28 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 7,930 F2: Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual restricted stock unit (RSU) award subject to the Exelon Long-term Incentive Plan (LTIP) will fully vest and be settled in shares of Exelon common stock on a 1 for 1 basis. The award will accrue additional stock units through dividend reinvestment which will vest along with the underlying award.
F2: Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.
ILLUMINA, INC.
Report date May 21, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,527 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 2,072 · Balance 8,527 F1: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Adamas Pharmaceuticals Inc
Report date November 24, 2021 · Filed November 24, 2021
Section 16 reporting ended · disclosed 2021-11-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-11-24 transaction · row 1
1 source rowRow 1 · 2021-11-24 · Other · Disposed 25,000 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of October 10, 2021, by and among the Issuer, Supernus Pharmaceuticals, Inc. ("Parent") and Supernus Reef, Inc., a wholly owned subsidiary of Parent ("Purchaser"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (each, a "Share") and thereafter merged with and into the Issuer (the "Merger") effective as of November 24, 2021 (the "Effective Time"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $8.10 in cash plus two contingent value rights ("CVRs" and, collectively with the cash amount, the "Per Share Price"). F2: A portion of this amount consists of unvested restricted stock units ("RSUs"). Pursuant to the terms of the Merger Agreement, each Issuer RSU that was outstanding immediately prior to the Effective Time was cancelled at the Effective Time and automatically converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding under applicable tax law, the Per Share Price. F3: Disposed of pursuant to Merger Agreement in exchange for $8.10 plus two CVRs per share. The CVRs do not have a market value. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.12 · Expires 2030-08-28 | Direct | 0 |
Reported balance
After 2021-11-24 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-11-24 · Disposition to issuer · Disposed 20,000 · Balance 0 F6: $2.98 plus two CVRs per share underlying the stock option. F4: The shares subject to the option vest annually in equal installments over 3 years. F5: Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and with a per share exercise price less than $8.10, was cancelled at the Effective Time and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, two CVRs plus the excess of (i) $8.10 over (ii) the per share exercise price of such Issuer option. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.21 · Expires 2031-06-01 | Direct | 0 |
Reported balance
After 2021-11-24 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-11-24 · Disposition to issuer · Disposed 10,000 · Balance 0 F7: $2.89 plus two CVRs per share underlying the stock option. F5: Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and with a per share exercise price less than $8.10, was cancelled at the Effective Time and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, two CVRs plus the excess of (i) $8.10 over (ii) the per share exercise price of such Issuer option. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of October 10, 2021, by and among the Issuer, Supernus Pharmaceuticals, Inc. ("Parent") and Supernus Reef, Inc., a wholly owned subsidiary of Parent ("Purchaser"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (each, a "Share") and thereafter merged with and into the Issuer (the "Merger") effective as of November 24, 2021 (the "Effective Time"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $8.10 in cash plus two contingent value rights ("CVRs" and, collectively with the cash amount, the "Per Share Price").
F2: A portion of this amount consists of unvested restricted stock units ("RSUs"). Pursuant to the terms of the Merger Agreement, each Issuer RSU that was outstanding immediately prior to the Effective Time was cancelled at the Effective Time and automatically converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding under applicable tax law, the Per Share Price.
F3: Disposed of pursuant to Merger Agreement in exchange for $8.10 plus two CVRs per share. The CVRs do not have a market value.
F4: The shares subject to the option vest annually in equal installments over 3 years.
F5: Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and with a per share exercise price less than $8.10, was cancelled at the Effective Time and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, two CVRs plus the excess of (i) $8.10 over (ii) the per share exercise price of such Issuer option.
F6: $2.98 plus two CVRs per share underlying the stock option.
F7: $2.89 plus two CVRs per share underlying the stock option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 26, 2011 Filed Apr 28, 2011 01:20 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 918 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-013894 · form4.xml · nonDerivative · entry 3 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,311 F2 · kind: These shares are being transferred to the reporting person's Family Trust. F3 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 2,500 RSUs which vest on 7/31/2011; 1,686 RSUs which vest in two equal annual installments of 843 each commencing 4/29/2011; 4,275 RSUs which vest in three equal annual installments of 1,425 each commencing 4/28/2011; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; 20,000 RSUs which vest on 10/28/2013; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 26, 2011 Filed Apr 28, 2011 01:20 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 532 | $54.69 | $29,095.08 |
DisclosureSEC source: 0001127602-11-013894 · form4.xml · nonDerivative · entry 2 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,229 Read SEC document |
| April 25, 2011 Filed Apr 28, 2011 01:20 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 26,250 | $54.69 Strike: $54.69 | $1,435,612.50 |
DisclosureSEC source: 0001127602-11-013894 · form4.xml · derivative · entry 6 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Underlying: Common Stock · 26,250 shares Expires 2021-04-25 F5 · derivative.exercise_date: These non-qualified stock options are exercisable in three annual installments of 33%, 33% and 34% on 4/25/2013, 4/25/2014 and 4/25/2015, respectively. Read SEC document |
| April 25, 2011 Filed Apr 28, 2011 01:20 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-013894 · form4.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,761 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/25/2013, 4/25/2014 and 4/25/2015, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 14, 2011 Filed Mar 15, 2011 22:43 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-010296 · form4.xml · nonDerivative · entry 3 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust Disclosed balance after: 4,164 F1 · kind: These shares are being transferred to the reporting person's Family Trust. Read SEC document |
| March 14, 2011 Filed Mar 15, 2011 22:43 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-010296 · form4.xml · nonDerivative · entry 2 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,261 F1 · kind: These shares are being transferred to the reporting person's Family Trust. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,500 RSUs which vest on 7/31/2011; 1,686 RSUs which vest in two equal annual installments of 843 each commencing 4/29/2011; 4,275 RSUs which vest in three equal annual installments of 1,425 each commencing 4/28/2011; 5,800 RSUs which vest in four equal annual installments of 1,450 each commencing 4/26/2011; and 20,000 RSUs which vest on 10/28/2013. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 11, 2011 Filed Mar 15, 2011 22:43 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 903 | $51.84 | $46,811.52 |
DisclosureSEC source: 0001127602-11-010296 · form4.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,818 Read SEC document |
| March 02, 2011 Filed Mar 5, 2011 00:36 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 2,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-009095 · form4.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,721 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,500 RSUs which vest on 7/31/2011; 1,686 RSUs which vest in two equal annual installments of 843 each commencing 4/29/2011; 4,275 RSUs which vest in three equal annual installments of 1,425 each commencing 4/28/2011; 5,800 RSUs which vest in four equal annual installments of 1,450 each commencing 4/26/2011; and 20,000 RSUs which vest on 10/28/2013. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| October 28, 2010 Filed Oct 29, 2010 22:08 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-026229 · form4.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,261 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Company's 2009 Equity Incentive Plan and fully vest on October 28, 2013. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 2,500 RSUs which vest on 7/31/2011; 1,686 RSUs which vest in two equal annual installments of 843 each commencing 4/29/2011; 4,275 RSUs which vest in three equal annual installments of 1,425 each commencing 4/28/2011; 5,800 RSUs which vest in four equal annual installments of 1,450 each commencing 4/26/2011; and 20,000 RSUs which vest on 10/28/2013. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| October 26, 2010 Filed Oct 27, 2010 23:35 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 5,900 | $0.00 Strike: $42.13 | $0.00 |
DisclosureSEC source: 0001127602-10-026087 · form4.xml · derivative · entry 5 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,900 Underlying: Common Stock · 5,900 shares Expires 2015-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is exercisable in four equal annual installments of 2,950 each commencing April 29, 2009. Read SEC document |
| October 26, 2010 Filed Oct 27, 2010 23:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,900 | $56.94 | $335,954.26 |
DisclosureSEC source: 0001127602-10-026087 · form4.xml · nonDerivative · entry 2 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,261 F1 · price: The price reported is an average price. The prices ranged from $56.9400 to $56.9420 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,500 RSUs which vest on 7/31/2011; 1,686 RSUs which vest in two equal annual installments of 843 each commencing 4/29/2011; 4,275 RSUs which vest in three equal annual installments of 1,425 each commencing 4/28/2011; and 5,800 RSUs which vest in four equal annual installments of 1,450 each commencing 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| October 26, 2010 Filed Oct 27, 2010 23:35 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 5,900 | $42.13 | $248,567.00 |
DisclosureSEC source: 0001127602-10-026087 · form4.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2010 Filed Aug 31, 2010 23:40 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 3,000 | $52.34 | $157,020.00 |
DisclosureSEC source: 0001127602-10-022235 · form4.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust Disclosed balance after: 2,607 Read SEC document |
| July 31, 2010 Filed Aug 3, 2010 22:32 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,583 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-020576 · form4.xml · nonDerivative · entry 3 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust Disclosed balance after: 5,607 F3 · balance_after: These shares include 433 shares of common stock acquired under the Company's Employee Stock Purchase Plan on June 15, 2010. Read SEC document |
| July 31, 2010 Filed Aug 3, 2010 22:32 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,583 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-020576 · form4.xml · nonDerivative · entry 2 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,261 F1 · shares: Shares are being transferred to the Reporting Person's Family Trust. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,500 RSUs which vest on 7/31/2011; 1,686 RSUs which vest in two equal annual installments of 843 each commencing 4/29/2011; 4,275 RSUs which vest in three equal annual installments of 1,425 each commencing 4/28/2011; and 5,800 RSUs which vest in four equal annual installments of 1,450 each commencing 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| July 31, 2010 Filed Aug 3, 2010 22:32 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 917 | $54.53 | $50,004.01 |
DisclosureSEC source: 0001127602-10-020576 · form4.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,844 Read SEC document |
| June 02, 2010 Filed Jun 3, 2010 18:19 UTC | AMGEN INC AMGN · Entity 2832 | Disposition to issuerCommon Stock | 2,000 | $55.17 | $110,340.00 |
DisclosureSEC source: 0001127602-10-016279 · form4.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust Disclosed balance after: 3,591 Read SEC document |
| April 29, 2010 Filed Apr 30, 2010 22:58 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 533 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-012679 · form4.xml · nonDerivative · entry 6 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust Disclosed balance after: 5,591 Read SEC document |
| April 29, 2010 Filed Apr 30, 2010 22:58 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 533 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-012679 · form4.xml · nonDerivative · entry 5 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,761 F1 · shares: Shares are being transferred to the Reporting Person's Family Trust. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,000 RSUs which vests in three equal annual installments of 2,500 each commencing 7/31/2010; 1,686 RSUs which vest in two equal annual installments of 843 each commencing 4/29/2011; 4,275 RSUs which vests in three equal annual installments of 1,425 each commencing 4/28/2011; and 5,800 RSUs which vest in four equal installments of 1,450 each commencing 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 29, 2010 Filed Apr 30, 2010 22:58 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 310 | $58.18 | $18,035.80 |
DisclosureSEC source: 0001127602-10-012679 · form4.xml · nonDerivative · entry 4 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,294 Read SEC document |
| April 28, 2010 Filed Apr 30, 2010 22:58 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 902 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-012679 · form4.xml · nonDerivative · entry 3 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust Disclosed balance after: 5,058 Read SEC document |
| April 28, 2010 Filed Apr 30, 2010 22:58 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 902 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-012679 · form4.xml · nonDerivative · entry 2 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,604 F1 · shares: Shares are being transferred to the Reporting Person's Family Trust. Read SEC document |
| April 28, 2010 Filed Apr 30, 2010 22:58 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 523 | $57.84 | $30,250.32 |
DisclosureSEC source: 0001127602-10-012679 · form4.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,506 Read SEC document |
| April 26, 2010 Filed Apr 28, 2010 19:40 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 40,000 | $58.43 Strike: $58.43 | $2,337,200.00 |
DisclosureSEC source: 0001127602-10-012261 · form4.xml · derivative · entry 4 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2020-04-26 F4 · derivative.exercise_date: These options are exercisable in four equal annual installments of 25% each commencing 04/26/2011. Read SEC document |
| April 26, 2010 Filed Apr 28, 2010 19:40 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 5,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-012261 · form4.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,029 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Company's 2009 Equity Incentive Plan and vest in four equal annual installments of 25% each commencing April 26, 2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 5,000 RSUs which vest in two equal annual installments of 2,500 each commencing 7/31/2010; 2,529 RSUs which vest in three equal annual installments of 843 each commencing 4/29/2010; 5,700 RSUs which vest in four equal annual installments of 1,425 each commencing 4/28/2010; and 5,800 RSUs which vest in four equal annual installments of 1,450 each commencing on 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 12, 2010 Filed Mar 16, 2010 19:38 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-008782 · form4.xml · nonDerivative · entry 4 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust Disclosed balance after: 4,156 F1 · kind: Shares are being transferred to the Reporting Person's Family Trust. Read SEC document |
| March 12, 2010 Filed Mar 16, 2010 19:38 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-008782 · form4.xml · nonDerivative · entry 3 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,229 F1 · kind: Shares are being transferred to the Reporting Person's Family Trust. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 5000 RSUs which vests in two equal annual installments of 2,500 each commencing 7/31/2010; 2,529 RSUs which vest in three equal annual installments of 843 each commencing 4/29/2010; and 5,700 RSUs which vests in four equal annual installments of 1,425 each commencing 4/28/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| March 12, 2010 Filed Mar 16, 2010 19:38 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 870 | $57.49 | $50,016.30 |
DisclosureSEC source: 0001127602-10-008782 · form4.xml · nonDerivative · entry 2 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,729 Read SEC document |
| March 12, 2010 Filed Mar 16, 2010 19:38 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 2,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-008782 · form4.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,599 Read SEC document |
| February 22, 2010 Filed Feb 24, 2010 20:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 350 | $57.00 | $19,950.00 |
DisclosureSEC source: 0001127602-10-006066 · form4.xml · nonDerivative · entry 2 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust Disclosed balance after: 2,656 Read SEC document |
| February 22, 2010 Filed Feb 24, 2010 20:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 100 | $57.00 | $5,700.30 |
DisclosureSEC source: 0001127602-10-006066 · form4.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust Disclosed balance after: 3,006 Read SEC document |
| November 05, 2009 Filed Nov 7, 2009 00:19 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 600 | $53.65 | $32,190.00 |
DisclosureSEC source: 0001127602-09-022055 · form4.xml · nonDerivative · entry 7 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust Disclosed balance after: 6,212 Read SEC document |
| November 05, 2009 Filed Nov 7, 2009 00:19 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 100 | $53.63 | $5,363.00 |
DisclosureSEC source: 0001127602-09-022055 · form4.xml · nonDerivative · entry 6 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust Disclosed balance after: 6,812 Read SEC document |
| November 05, 2009 Filed Nov 7, 2009 00:19 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 300 | $53.61 | $16,083.00 |
DisclosureSEC source: 0001127602-09-022055 · form4.xml · nonDerivative · entry 5 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust Disclosed balance after: 6,912 Read SEC document |
| November 05, 2009 Filed Nov 7, 2009 00:19 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 600 | $53.60 | $32,160.00 |
DisclosureSEC source: 0001127602-09-022055 · form4.xml · nonDerivative · entry 4 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust Disclosed balance after: 7,212 Read SEC document |
| November 05, 2009 Filed Nov 7, 2009 00:19 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 400 | $53.61 | $21,444.44 |
DisclosureSEC source: 0001127602-09-022055 · form4.xml · nonDerivative · entry 3 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust Disclosed balance after: 7,812 Read SEC document |
| August 31, 2009 Filed Nov 7, 2009 00:19 UTC | AMGEN INC AMGN · Entity 2832 | OtherCommon Stock | 5,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-022055 · form4.xml · nonDerivative · entry 2 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust Disclosed balance after: 8,212 F1 · kind: These shares, which Iincludes 423 shares acquired under the Company's Employee Stock Purchase Plan on June 30, 2009, are being transferred to the Family Trust. Read SEC document |
| August 31, 2009 Filed Nov 7, 2009 00:19 UTC | AMGEN INC AMGN · Entity 2832 | OtherCommon Stock | 5,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-022055 · form4.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,229 F1 · kind: These shares, which Iincludes 423 shares acquired under the Company's Employee Stock Purchase Plan on June 30, 2009, are being transferred to the Family Trust. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 5,000 RSUs which vests in two equal annual installments of 2,500 each commencing 7/31/2010; 2,529 RSUs which vest in three equal annual installments of 843 each commencing 4/29/2010; and 5,700 RSUs which vests in four equal annual installments of 1,425 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| July 31, 2009 Filed Jul 31, 2009 22:56 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 894 | $63.11 | $56,420.34 |
DisclosureSEC source: 0001127602-09-016480 · form4.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,335 F1 · security: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 5,000 RSUs which vests in two equal annual installments of 2,500 each commencing 7/31/2010; 2,529 RSUs which vest in three equal annual installments of 843 each commencing 4/29/2010; and 5,700 RSUs which vests in four equal annual installments of 1,425 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| May 22, 2009 Filed May 22, 2009 21:47 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,098 | $49.75 | $54,625.50 |
DisclosureSEC source: 0001127602-09-012179 · form4.xml · nonDerivative · entry 2 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,806 F1 · security: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 7,500 RSUs which vests in three equal annual installments of 2,500 each commencing 7/31/2009; 2,529 RSUs which vest in three equal annual installments of 843 each commencing 4/29/2010; and 5,700 RSUs which vests in four equal annual installments of 1,425 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. F3 · balance_after: In the immediately preceding filing, the Reporting Person reported the disposition of 302 shares which were withheld to satisfy tax obligation resulting from vesting of performance units; whereas, the balance reflected the withholding of twice the amount. The balance has been adjusted to reflect the single withholding. Read SEC document |
| May 22, 2009 Filed May 22, 2009 21:47 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,402 | $49.74 | $69,735.48 |
DisclosureSEC source: 0001127602-09-012179 · form4.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,904 F1 · security: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 7,500 RSUs which vests in three equal annual installments of 2,500 each commencing 7/31/2009; 2,529 RSUs which vest in three equal annual installments of 843 each commencing 4/29/2010; and 5,700 RSUs which vests in four equal annual installments of 1,425 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| May 08, 2009 Filed May 8, 2009 22:44 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 832 | $47.63 | $39,628.16 |
DisclosureSEC source: 0001127602-09-011042 · form4.xml · nonDerivative · entry 2 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,004 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 7,500 RSUs which vests in three equal annual installments of 2,500 each commencing 7/31/2009; 2,529 RSUs which vest in three equal annual installments of 843 each commencing 4/29/2010; and 5,700 RSUs which vests in four equal annual installments of 1,425 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| May 07, 2009 Filed May 8, 2009 22:44 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 2,327 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-011042 · form4.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,836 Read SEC document |
| April 29, 2009 Filed May 1, 2009 22:55 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 302 | $50.44 | $15,232.88 |
DisclosureSEC source: 0001127602-09-010341 · form4.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,509 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 7,500 RSUs which vests in three equal annual installments of 2,500 each commencing 7/31/2009; 2,529 RSUs which vest in three equal annual installments of 843 each commencing 4/29/2010; and 5,700 RSUs which vests in four equal annual installments of 1,425 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| April 28, 2009 Filed Apr 30, 2009 20:46 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $50.44 | $0.00 |
DisclosureSEC source: 0001127602-09-010116 · form4.xml · derivative · entry 4 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2016-04-28 F4 · derivative.exercise_date: These shares are exercisable in four equal annual installments of 25% each commencing 04/28/2010. Read SEC document |
| April 28, 2009 Filed Apr 30, 2009 20:46 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-010116 · form4.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,700 F1 · security: The Restricted Stock Units (RSUs) were granted pursuant to the Company's Amended and Restated 1991 Equity Incentive Plan (the "1991 Plan"). RSUs vest in four equal annual installments of 25% each commence April 28, 2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 20:22 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 4,400 | $54.85 | $241,340.00 |
DisclosureSEC source: 0001181431-08-058386 · rrd221583.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,912 F1 · balance_after: The amount of the Company?s Common Stock beneficially owned at the end of the month and held directly by the reporting person has been adjusted to reflect an acquisition of the Company?s Common Stock under the 423(b) Plan in a transaction exempt pursuant to Rule 16a-3(f)(1)(k)(B). Read SEC document |
| October 23, 2008 Filed Mar 4, 2009 20:52 UTC Amendment | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 4,400 | $54.85 | $241,340.00 |
DisclosureSEC source: 0001181431-09-013540 · rrd236139.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,580 F1 · security: This amendment is to amend and restate reporting person's Form 4 to include the shares held by the reporting person, which was inadvertently omitted from the reporting person's original Form 3 that was filed. F2 · balance_after: These shares include 10,872 restricted stock units granted under the Company's Amended and Restated 1991 Equity Incentive Plan of which 10,000 RSU's vest in four equal installments of 2,500 shares each commencing 7/17/2008 and 3,372 RSUs vest in four equal installments of 843 shares each commencing 4/29/2009. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| October 23, 2008 Filed Mar 5, 2009 23:21 UTC Amendment | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 4,400 | $54.85 | $241,340.00 |
DisclosureSEC source: 0001181431-09-014007 · rrd236524.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,541 F1 · balance_after: This amendment is to amend and restate reporting person's Form 4 to include the shares held by the reporting person, which was inadvertently omitted from the reporting person's original Form 3 that was filed. Read SEC document |
| July 31, 2008 Filed Aug 2, 2008 00:28 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 20,500 | $62.63 Strike: $62.63 | $1,283,915.00 |
DisclosureSEC source: 0001181431-08-045651 · rrd214626.xml · derivative · entry 3 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,500 Underlying: Common Stock · 20,500 shares Expires 2015-07-31 F2 · derivative.exercise_date: This option is exercisable in four equal annual installments of 5,125 shares each commencing July 31, 2009. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.